DNA Synthesis Market Size Worth USD 17.36 Billion by 2034 | CAGR: 18.65%

The DNA synthesis market size is expected to reach USD 17.36 Billion by 2034, according to a new study by Polaris Market Research. The report “DNA Synthesis Market Size, Share, Trends, Industry Analysis Report By Type (Oligonucleotide Synthesis and Gene Synthesis), By Application, By End-User, and By Region – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The DNA synthesis market is witnessing rapid adoption across biotechnology, pharmaceutical, and academic research sectors. It enables precise, high-throughput, and customizable production of DNA sequences while overcoming the time, accuracy, and scalability limitations of traditional methods.

Questions? Request a sample or make an inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/dna-synthesis-market/request-for-sample

The market is experiencing significant growth driven by increasing demand for synthetic biology applications, gene editing, and precision medicine, alongside expanding use in genomics, diagnostics, and therapeutic development. Surge in technological innovations, coupled with rising investments from government bodies and private organizations, are further accelerating the integration of DNA synthesis solutions across research and industrial applications.

DNA Synthesis Market Report Highlights

• Based on type, the oligonucleotide synthesis segment dominated the market in 2024, owing to its extensive application in PCR assays, next-generation sequencing, molecular diagnostics, and targeted therapeutic research that demand high-quality synthetic DNA.
• In terms of application, the diagnostics segment held the largest share in 2024, driven by increasing adoption of DNA-based assays, biomarker discovery, and infectious disease detection across healthcare, research, and clinical settings.
• Based on end-user, pharmaceutical and biotechnology companies led the market in 2024, supported by growing utilization of DNA synthesis in drug discovery, development of gene therapies, biologics, and research-driven innovation.
• North America held dominant market share in 2024, attributed to the strong presence of leading biotechnology and pharmaceutical companies, advanced research infrastructure, and substantial R&D investments in genomics and life sciences.
• Asia Pacific is projected to record the fastest growth during the forecast period, fueled by rising investments in genomics, molecular diagnostics, and vaccine development.
•  Key players in the global market include BIONEER CORPORATION, Camena Bioscience Ltd., DNA Script SAS, Eton Bioscience, Inc., Eurofins Scientific SE, GenScript Biotech Corporation, IBA Lifesciences GmbH, Integrated DNA Technologies, Inc., LGC Biosearch Technologies Limited, Molecular Assemblies, Inc., Quintara Biosciences, Inc., Synbio Technologies, Inc., Thermo Fisher Scientific, Inc., Touchlight Genetics Ltd., and Twist Bioscience Corporation.

Polaris Market Research has segmented the market report based on type, application, end-user, and region:

By Type Outlook (Revenue, USD Billion, 2020–2034)

• Oligonucleotide Synthesis
• Gene Synthesis

By Application Outlook (Revenue, USD Billion, 2020–2034)

• Diagnostics    
  • Infectious Diseases
  • Cancer
  • Others
• Therapeutics  
  • Gene Therapy
  • Preventive Medicine
  • Others
• Research & Development      
  • Cloning and Gene Editing
  • Drug Discovery & Development
  • Others

By End-User Outlook (Revenue, USD Billion, 2020–2034)

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs) & Contract Development and Manufacturing Organizations (CDMOs)
• Others

By Regional Outlook (Revenue, USD Billion, 2020–2034)

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America